Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dopamine receptor D5 pseudogene 2 (DRD5P2) is a pseudogene closely related to the functional dopamine receptor D5 (DRD5). While the authentic DRD5 gene encodes a protein that is a G protein-coupled receptor (GPCR) involved in dopamine signaling, DRD5P2 is a non-functional DNA segment that arose by gene duplication and sequence divergence[1][3][7][8]. It shares high sequence similarity (over 95%) with the functional DRD5 gene, but contains insertions, deletions, and multiple in-frame stop codons, which prevent it from producing a functional protein[1][3][5][7]. Transcription of DRD5P2 can occur, but the RNA product is not translated into a receptor protein, and thus DRD5P2 has no established biological function, disease association, or pharmacologic relevance[1][3][7]. It is not considered a therapeutic target and has no known role in drug interaction, mechanism of action, or as a disease biomarker. Key clarification: - DRD5P2 is a pseudogene and not a true protein-coding gene, receptor, or drug target. - Some databases may list it alongside the functional DRD5 gene, but only DRD5 (not DRD5P2) encodes the G protein-coupled dopamine receptor implicated in drug response and neurobiology[1][3][7][8]. - If you are interested in the actual dopamine D5 receptor, refer to "Dopamine receptor D5" (DRD5). Summary: Dopamine receptor D5 pseudogene 2 (DRD5P2) is a pseudogene related to, but functionally distinct from, the true dopamine receptor D5. DRD5P2 does not encode a functional protein and is not a therapeutic or pharmacologic target[1][3][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine receptor D5 pseudogene 2 (DRD5P2).